News and Updates

New research indicates medical cannabis may safely reduce agitation in dementia patients, offering a potential alternative to traditional antipsychotics.

The FDA has approved the subcutaneous injection of Leqembi for early Alzheimer’s. Learn how this new delivery method impacts patient care and treatment.

The FDA has issued final guidance for psychedelic drug clinical trials, offering new clarity on safety, study design, and patient monitoring protocols.

New research confirms bariatric surgery is a safe, effective option for treating severe obesity in adolescents, improving long-term metabolic health outcomes.

The FDA rejects Hengrui-Elevar's liver cancer drug for the third time, while GSK prepares for an FDA filing to expand Jemperli for rectal cancer treatment.

New stem cell therapy advances to clinical trials, offering hope for spinal cord injury recovery through regenerative nerve cell transplantation.

A new clinical trial is testing a breakthrough drug for weight management. Discover how this potential treatment could impact metabolic health and diabetes.

The US FDA issued a warning letter to a clinical investigator at an Alembic bioequivalence site over concerns regarding data integrity and study oversight.

New research suggests ibuprofen may safely reduce inflammation in drug-resistant tuberculosis patients, potentially improving outcomes for MDR-TB recovery.

Massive Bio and Sequence Me Now partner to revolutionize cancer clinical trial recruitment using AI to connect patients with precision medicine research.